The new MDR compliance challenge

The new MDR compliance challenge

26th May 2020 marks the end of the transition period from the old Medical Device Directive (MDD) to the new Medical Device Regulations (MDR) 2017/745.

From this date, the MDR will be in full effect and EU-based medical device manufacturers will be required to provide updated technical documentation to meet the standards of the new legislative framework.

Across the industry, medical device companies are facing challenges in meeting the demands of the new legislative framework. Long-held claims of equivalence are no longer valid and the need to evidence every indication is placing huge demands on evidence-generation systems that are difficult to meet.

At Mantra Systems, we are experts at solving these problems. Allow us to be your cost-effective specialist MDR Compliance partner.

Why has the Medical Device Directive (MDD) been replaced?

Although generally robust and relatively permissive of innovation, the MDD was considered to have numerous flaws in enforcing medical device safety, reliability and general product quality, exposed by notorious incidents such as the metal-on-metal hip scandal. Legislators were compelled to implement reform.

The new MDR attempts to reduce the likelihood of future incidents of this nature by tightening the requirements for proving safety and effectiveness of all medical devices, regardless of how long the product has been on the market.

How will the industry be affected?

From an industry perspective, the most important changes are the need to provide evidence "on an ongoing basis" to support every individual indication, in parallel with the reduced capacity to claim equivalence to devices already approved for sale.

These changes mean that manufacturers across the industry face a significantly increased evidence-generation burden, meaning a potentially huge increase in cost to meet the demands for medical device compliance. In some cases, this may even challenge the commercial viability of a product.

Mantra Systems is the answer to this dilemma. We are experts at navigating the evidence-generation requirements of MDR and will ensure that you have the systems in place to meet the demands of the new legislation.

How can Mantra Systems help you?

Obtaining a medical device CE-Mark under MDR requires robust clinical evidence in the form of Real world evidence (RWE), built from real world data (RWD). Generating RWE is difficult and resource-intensive. Our experienced specialists will work with you to design and
 develop your real world evidence generation system to the highest level of legal and regulatory compliance.

Our MEDDEV 2.12-based systems ensure full harmonization of
 data collection standards across multiple locations in full adherence to GDPR and all relevant ISO standards.

If you have any questions about this article, please contact us and we will be happy to answer them.

  • Author: Dr Paul Hercock, CEO
  • Posted:

Related Medical Device Regulation services

  1. Real World Evidence Generation Systems

    Real World Evidence Generation Systems

    We will design and deliver Real World Evidence (RWE) Generation Systems in the form of a Medical Device Product Registry that will enable your company to generate RWE in a way that complies fully with all relevant legislative and regulatory obligations including MDR, GDPR, ISO 13485, ISO 14971 and ISO 14155.

  2. Clinical Evaluation Report (CER) as a writing service

    Clinical Evaluation Report

    The CER is an essential component of every medical device regulatory submission. New regulatory obligations imposed by MDR mean it is more challenging to draft technical documentation. We are highly experienced in drafting CERs in accordance with MEDDEV 2.7/1 rev 4 and guarantee your CERs will be fully MDR compliant.

  3. Post Market Surveillance Conduct

    Post-Market Surveillance conduct

    Our expertise in handling and assessing Medical Complaints, analysing clinical evidence gaps, performing risk analysis and building RWE Generation Systems allows us to be your holistic Post-Market Surveillance System generation partner.

  4. Clinical Evidence Application Training for medical device manufacturer's sales teams

    Clinical Evidence Application Training

    Generating clinical data is expensive and time-consuming. While the primary objective in doing so may be to ensure MDR compliance of your devices, Mantra Systems can ensure that your sales team can effectively use this data to support sales calls.

If you have any enquires about our services, contact our team today.

Make an enquiry

Other Medical Device Regulation articles

  1. Sources of Real World Evidence for medical device regulation compliance

    Sources of Real World Evidence

    There are multiple ways to generate RWE. At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    • Dr Paul Hercock, CEO

Do you have any questions about our services?

Contact us